A clinical trial in New Zealand found a virtual reality app-based cognitive behaviour therapy programme reduced the symptoms of common phobias.
FINDINGS
Conducted between May and December last year, the randomised, controlled trial recruited a total of 129 adult participants with fears of flying, heights, needles, spiders and dogs. It was led by Dr Cameron Lacey, associate professor from the...
The University of Southern Queensland in Australia has disclosed that a global research team is developing a unique classification system for the early detection of autism in children.
WHAT IT'S ABOUT
In a study, whose findings were published in the journal Complex & Intelligent Systems, the researchers examined and tested two sets of nonlinear, highly distinctive features of EEG signals...
Holmusk, a health tech firm based in Singapore and New York, has signed deals to use patient data from the University of Texas Health Science Center and the Harris Center for Mental Health and IDD to develop AI-powered analytic tools.
WHY IT MATTERS
The company will help create longitudinal patient records in both centres, which are still storing data in various legacy electronic health record...
Sydney-headquartered telehealth platform Eucalyptus has recently bagged A$30 million ($22.4 million) in a Series B funding round led by NewView Capital, the Silicon Valley-based investor that also backs digital health firms 23andMe and Hims & Hers. The investing round also saw participation from previous investors Blackbird Ventures and W23, as well as new investor AirTree Ventures.
WHAT IT...
New Jersey-based Otsuka Pharmaceutical Development & Commercialization has signed a three-year collaboration with Holmusk, a data science and digital health firm based in Singapore and New York. The deal is worth up to $4 million annually.
WHAT THEY DO
OPDC is an indirect unit of Otsuka Pharmaceutical Company, which is a subsidiary of Japan-based Otsuka Holdings. It develops and manufactures...
![[Left] Adam Hutchinson, founder of oVRcome, and [Right] Dr Cameron Lacey of the University of Otago](https://www.mobihealthnews.com/sites/default/files/styles/230x130/public/1630195915719.jpg?itok=Kolmo1bB)
